Log in to save to my catalogue

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in dev...

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in dev...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_911150110

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

About this item

Full title

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

Publisher

Kidlington: Elsevier Ltd

Journal title

The Lancet (British edition), 2010-08, Vol.376 (9741), p.606-614

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Rotavirus gastroenteritis causes many deaths in infants in sub-Saharan Africa. Because rotavirus vaccines have proven effective in developed countries but had not been tested in developing countries, we assessed efficacy of a pentavalent rotavirus vaccine against severe disease in Ghana, Kenya, and Mali between April, 2007, and M...

Alternative Titles

Full title

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_911150110

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_911150110

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(10)60889-6

How to access this item